SG/PUT/AMGEN/250/0.1/20.09.24 | Market Closed - Deutsche Boerse AG 20:50:22 28/06/2024 BST | ||
| 0.1 EUR | 0.00% |
|
| Current month | -47.37% | ||
| 1 month | -52.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 0.1 | 0.00% |
| 27/06/24 | 0.1 | +11.11% |
| 26/06/24 | 0.09 | +18.42% |
| 25/06/24 | 0.076 | -3.80% |
| 24/06/24 | 0.079 | -28.18% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 08:50 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SW38XM |
| ISIN | DE000SW38XM8 |
| Date issued | 03/10/2023 |
| Strike | 250 $ |
| Maturity | 20/09/2024 (84 Days) |
| Parity | 10 : 1 |
| Emission price | 1.57 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.12 € |
|---|---|
| Lowest since issue | 0.058 € |
| Spread | 0.01 € |
| Spread % | 9.09% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
312.4
USD
Average target price
316.4
USD
Spread / Average Target
+1.28%
- Stock Market
- Warrants
- Warrant
